FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Ethiodized Oil (Lipiodol) Injection
Status: Currently in Shortage
»Date first posted: 06/24/2015
»Therapeutic Categories: Medical Imaging; Oncology

Guerbet LLC (Revised 06/17/2016)

Company Contact Information:
877-729-6679

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Box of one 10 mL ampoule (NDC 67684-1901-1) Available Guerbet, in conjunction with the FDA, is initiating a temporary importation of Lipiodol Ultra-Fluide, ethryl esters of iodized fatty acids of poppy seed oil, to the United States market. Please see the Dear Healthcare Provider Letter.

Dear Healthcare Provider Letter

Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English